Olympus (TSE:7733) EBIT: 円103,291 Mil (TTM As of Mar. 2026)


TSE:7733 Olympus Corp TSE:7733
76 GF Score
Price 円1,684.00
GF Value 円2,593.47
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Olympus EBIT?

Olympus TSE:7733 +2.97% 76 EBIT is 円103,291 Mil as of Mar. 2026. GuruFocus rates TSE:7733 with a GF Score™ of 76/100 and a GF Value™ of 円2,593.47 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Olympus's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円27,594 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円103,291 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Olympus's annualized ROC % for the quarter that ended in Mar. 2026 was 8.27%. Olympus's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 26.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Olympus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.70%.


Olympus  (TSE:7733) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Olympus's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=107464 * ( 1 - 8.36% )/( (1173519 + 1209229)/ 2 )
=98480.0096/1191374
=8.27 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Olympus's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=110376/( ( (285361 + max(133357, 0)) + (287209 + max(132851, 0)) )/ 2 )
=110376/( ( 418718 + 420060 )/ 2 )
=110376/419389
=26.32 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(196882 + 214967 + 44059) - (87656 + 0 + 234895)
=133357

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(236833 + 207092 + 45924) - (111474 + 0 + 245524)
=132851

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Olympus's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=103291/1811791.436
=5.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus EBIT Related Terms


Olympus EBIT Historical Data

* Premium members only.

The historical data trend for Olympus's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus EBIT Chart

Olympus Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 147,539.00 190,469.00 53,907.00 165,911.00 103,291.00

Olympus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54,398.00 18,042.00 33,180.00 24,475.00 27,594.00

TSE:7733 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Olympus's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Olympus's EV-to-EBIT falls into.


TSE:7733
76GF Score
Olympus Corp TSE:7733
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olympus EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円103,291 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円103,291 Mil mean?
Olympus (TSE:7733) has a EBIT of 円103,291 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Olympus.
Is Olympus' EBIT too high?
Olympus' current EBIT is 円103,291 Mil. Overall, Olympus has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olympus' EBIT compare to ABT and SYK?
Olympus' EBIT of 円103,291 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Olympus. Olympus's current EBIT is 円103,291 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olympus stock overvalued right now?
Based on GuruFocus' analysis, Olympus (TSE:7733) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,593.47, compared to a current price of 円1,684.00 — trading 35.1% below its estimated fair value. The current EBIT is 円103,291 Mil. Olympus' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Olympus (TSE:7733), the current EBIT is 円103,291 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Olympus (TSE:7733) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of 円1,684.00 is trading 35.1% below its estimated GF Value™ of 円2,593.47. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for TSE:7733:

  • EBIT: 円103,291 Mil
  • GF Value™: 円2,593.47 vs. price of 円1,684.00 (35.1% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the TSE:7733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
76GF Score

Get the complete analysis for TSE:7733

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,684.00
Price
円2,593.47
GF Value